2022
DOI: 10.1021/acs.jafc.2c02836
|View full text |Cite
|
Sign up to set email alerts
|

Release of Small Phenolic Metabolites from Isotopically Labeled 13C Lignin in the Pig Cecum Model

Abstract: A diet with a high dietary fiber content is often recommended in today's nutrition due to several beneficial health effects related to its intake. Lignin as a part of dietary fiber is the second most abundant natural polymer and considered to be stable during digestion. However, some studies indicate a partial degradation during the intestinal metabolism. To further elucidate this hypothesis, the aim of this study was to investigate whether lignin is metabolized by the gut microbiota using the ex vivo pig cecu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(9 citation statements)
references
References 35 publications
(123 reference statements)
0
9
0
Order By: Relevance
“…The incubations of steroidal glycoalkaloids in ACS and DCS were performed for incubation periods from 0 to 24 h (0, 15, 30, 60, 120, 240, 480, 1200, and 1440 min). The bacterial activity of each cecum was tested by incubation of quercetin and fluorescein diacetate in ACS as indicators for metabolically active microbiota. , Incubation of the analytes in DCS was used as a control to exclude matrix effects and chemical degradation of the compounds. For incubation experiments, the 1 mM stock solutions were diluted in methanol to obtain 10 μM incubation solutions.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The incubations of steroidal glycoalkaloids in ACS and DCS were performed for incubation periods from 0 to 24 h (0, 15, 30, 60, 120, 240, 480, 1200, and 1440 min). The bacterial activity of each cecum was tested by incubation of quercetin and fluorescein diacetate in ACS as indicators for metabolically active microbiota. , Incubation of the analytes in DCS was used as a control to exclude matrix effects and chemical degradation of the compounds. For incubation experiments, the 1 mM stock solutions were diluted in methanol to obtain 10 μM incubation solutions.…”
Section: Methodsmentioning
confidence: 99%
“…Tomatine, which is connected to a lycotetraose, was also included in the study to gain more data about the relevance of the glycosidic bond configuration for intestinal degradation. The pig cecum model is a powerful tool to elucidate the human intestinal metabolism, as specifically the microbiota in the gastrointestinal tract of humans and pigs is comparable, which was demonstrated by the characterization of the cecal microbiota using fluorescence in situ hybridization with 16S rRNA-based oligonucleotide probes and terminal-restriction fragment length polymorphisms of human and porcine stool samples. , It was successfully applied in several previous studies which investigated the intestinal metabolism of polyphenols modified mycotoxins, imidazole alkaloids or lignin . Obtained results should provide further information on the metabolism of selected SGA and reduce uncertainties on the risk assessment.…”
Section: Introductionmentioning
confidence: 99%
“…[10][11][12][13] An introducing of stable isotope labeled compounds in biological objects allows detailled studies of metabolic processes in living organisms, including studies of drugs pharmacokinetic profile. [14][15][16][17][18][19][20][21] Isotopes of organogenic elements are widely used as labels, among them carbon-13 seems to be the most versatile and promising, since it allows to introduce labels directly into the skeleton of organic molecules. In past decades, C 2 -labeled terminal acetylenes.…”
Section: Background and Originality Contentmentioning
confidence: 99%
“…[ 10‐13 ] An introducing of stable isotope labeled compounds in biological objects allows detailled studies of metabolic processes in living organisms, including studies of drugs pharmacokinetic profile. [ 14‐21 ]…”
Section: Background and Originality Contentmentioning
confidence: 99%
See 1 more Smart Citation